Johnson Chemical Pharmaceutical Works Co., Ltd. (TPEX:4747)
Taiwan · Delayed Price · Currency is TWD 25.25
+0.50 (2.02%)
Sep 8, 2026, 1:30 PM CST
TPEX:4747 Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 577.93 | 569.77 | 611.42 | 606.71 | 494.67 | 411.49 | |
Revenue Growth | -0.84% | -6.81% | 0.78% | 22.65% | 20.21% | -2.95% |
Cost of Revenue | 350.83 | 341.43 | 363.45 | 362.08 | 290.29 | 239.57 |
Gross Profit | 227.1 | 228.35 | 247.97 | 244.63 | 204.38 | 171.92 |
Selling, General & Admin | 154.26 | 139.28 | 129.21 | 128.45 | 108.45 | 100.72 |
Research & Development | 13.67 | 15.96 | 20.76 | 17.27 | 13.25 | 8.92 |
Operating Expenses | 168.15 | 155.01 | 149.77 | 145.8 | 122.58 | 109.64 |
Operating Income | 58.95 | 73.33 | 98.2 | 98.83 | 81.79 | 62.29 |
Interest Expense | -11.37 | -3.75 | -3.51 | -4.6 | -1.06 | -1.08 |
Interest & Investment Income | 11.53 | 13.95 | 13.24 | 6.33 | 0.49 | 0.57 |
Currency Exchange Gain (Loss) | - | -0 | 0.13 | 0.04 | 0.1 | -0.66 |
Other Non Operating Income (Expenses) | -33.86 | -33.84 | 1.09 | 0.28 | 0.21 | 0.83 |
EBT Excluding Unusual Items | 24.2 | 49.69 | 109.15 | 100.88 | 81.53 | 61.95 |
Gain (Loss) on Sale of Investments | 69.51 | 13.77 | -0.44 | - | - | - |
Gain (Loss) on Sale of Assets | - | -0.08 | - | 0.01 | - | -0.01 |
Pretax Income | 93.7 | 63.38 | 108.71 | 100.89 | 81.53 | 61.94 |
Income Tax Expense | 4.33 | 9.87 | 24.59 | 21.19 | 16.68 | 12.84 |
Net Income | 89.38 | 53.51 | 84.12 | 79.7 | 64.85 | 49.1 |
Net Income to Common | 89.38 | 53.51 | 84.12 | 79.7 | 64.85 | 49.1 |
Net Income Growth | 9.01% | -36.40% | 5.55% | 22.90% | 32.08% | -22.75% |
Shares Outstanding (Basic) | 91 | 90 | 90 | 71 | 60 | 60 |
Shares Outstanding (Diluted) | 93 | 93 | 93 | 76 | 60 | 60 |
Shares Change | -0.03% | 0.04% | 22.56% | 26.25% | -0.07% | -0.04% |
EPS (Basic) | 0.99 | 0.59 | 0.94 | 1.12 | 1.08 | 0.82 |
EPS (Diluted) | 0.97 | 0.59 | 0.93 | 1.09 | 1.08 | 0.81 |
EPS Growth | 7.94% | -36.20% | -14.69% | 0.88% | 32.52% | -22.75% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -40.87 | 7.66 | 49.68 | 103.84 | 29.98 | 15.06 |
Free Cash Flow Per Share | -0.44 | 0.08 | 0.53 | 1.37 | 0.50 | 0.25 |
Dividend Per Share | 0.525 | 0.525 | 0.875 | 0.750 | 1.000 | 0.725 |
Dividend Growth | -40.00% | -40.00% | 16.67% | -25.00% | 37.93% | -24.48% |
Gross Margin | 39.30% | 40.08% | 40.56% | 40.32% | 41.32% | 41.78% |
Operating Margin | 10.20% | 12.87% | 16.06% | 16.29% | 16.54% | 15.14% |
Profit Margin | 15.47% | 9.39% | 13.76% | 13.14% | 13.11% | 11.93% |
Free Cash Flow Margin | -7.07% | 1.34% | 8.13% | 17.11% | 6.06% | 3.66% |
EBITDA | 79.33 | 93.67 | 119.17 | 119.94 | 100.06 | 77.57 |
EBITDA Margin | 13.73% | 16.44% | 19.49% | 19.77% | 20.23% | 18.85% |
D&A For EBITDA | 20.38 | 20.34 | 20.97 | 21.11 | 18.27 | 15.29 |
EBIT | 58.95 | 73.33 | 98.2 | 98.83 | 81.79 | 62.29 |
EBIT Margin | 10.20% | 12.87% | 16.06% | 16.29% | 16.54% | 15.14% |
Effective Tax Rate | 4.62% | 15.58% | 22.62% | 21.00% | 20.46% | 20.73% |